Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Short-term Investments (2017 - 2025)

Historic Short-term Investments for Dr Reddys Laboratories (RDY) over the last 13 years, with Q4 2025 value amounting to $2.9 million.

  • Dr Reddys Laboratories' Short-term Investments changed N/A to $2.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 million, marking a year-over-year change of. This contributed to the annual value of $506.0 million for FY2025, which is 4327.35% down from last year.
  • Dr Reddys Laboratories' Short-term Investments amounted to $2.9 million in Q4 2025.
  • Dr Reddys Laboratories' 5-year Short-term Investments high stood at $895.4 million for Q1 2024, and its period low was $1.5 during Q2 2022.
  • Over the past 5 years, Dr Reddys Laboratories' median Short-term Investments value was $13.1 million (recorded in 2021), while the average stood at $148.6 million.
  • In the last 5 years, Dr Reddys Laboratories' Short-term Investments crashed by 10000.0% in 2022 and then soared by 148956047867.49% in 2023.
  • Quarter analysis of 5 years shows Dr Reddys Laboratories' Short-term Investments stood at $24.0 million in 2021, then plummeted by 90.83% to $2.2 million in 2022, then skyrocketed by 301.12% to $8.8 million in 2023, then crashed by 45.99% to $4.8 million in 2024, then tumbled by 39.1% to $2.9 million in 2025.
  • Its Short-term Investments was $2.9 million in Q4 2025, compared to $32.5 million in Q3 2025 and $6.4 million in Q1 2025.